logo
Select company
Select metric
-1408.67%EBIT Margin
VS
Market
5
Sector
17
Industry
32
History
100
$ 3.41Close
$ 1.66 - $ 3.9 52-Week Range
Ticker Information

Ticker

NUVB

Company Name

NUVATION BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSE

NUVATION BIO INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NUVB - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -202.21M-1408.67%$ 14.36M
3/31/2025$ -605.99M-5530.6%$ 10.96M
12/31/2024$ -567.6M-7209.42%$ 7.87M
9/30/2024$ -532.03M-24608.19%$ 2.16M
6/30/2024$ -510.59M-35581.05%$ 1.44M
3/31/2024$ -68.87M0%$ 0
12/31/2023$ -75.8M0%$ 0
9/30/2023$ -82.86M0%$ 0
6/30/2023$ -90.41M0%$ 0
3/31/2023$ -104.63M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NUVATION BIO INC's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, NUVATION BIO INC's average EBIT % has been -14867.58%.
  • The median EBIT % for NUVATION BIO INC during this period was -7209.42%
  • NUVATION BIO INC reached its highest EBIT % over the past 5 years at -1408.67%.
  • The lowest EBIT % recorded by NUVATION BIO INC in the same timeframe -35581.05%

NUVATION BIO INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
QURE : UNIQURE NV -942.05%ZBIO : ZENAS BIOPHARMA INC -1178.41%ABUS : ARBUTUS BIOPHARMA CORP -351.17%IMNM : IMMUNOME INC -1687.08%VIR : VIR BIOTECHNOLOGY INC -2894.48%TSHA : TAYSHA GENE THERAPIES INC -1143.96%CAPR : CAPRICOR THERAPEUTICS INC -522.51%RLAY : RELAY THERAPEUTICS INC -3728.45%BCYC : BICYCLE THERAPEUTICS PLC -1286.34%TNGX : TANGO THERAPEUTICS INC -598.4%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for NUVATION BIO INC is calculated as follows: EBIT [ $ -41.66M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

NUVB - EBIT Margin, Last 5 years

-35581.05%

Minimum

Jun 30, 2024

-1408.67%

Maximum

Jun 30, 2025

-14867.58%

Average

-7209.42%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%